Cargando…
Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
The conversion of what has been interpreted as “normal brain aging” to Alzheimer’s disease (AD) via transition states, i.e., preclinical AD and mild cognitive impairment, appears to be a continuous process caused primarily by aging-dependent accumulation of amyloid β peptide (Aβ) in the brain. This...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758963/ https://www.ncbi.nlm.nih.gov/pubmed/23883611 http://dx.doi.org/10.2183/pjab.89.321 |